Assorted Milk Chocolate Royal Icing Pops sold as Assorted Character Icing Pops, Christmas Icing Pops, and Triple Heart Icing Pops, 24 pop...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1581-2015.
The products contain undeclared egg and FD&C colors Yellow 5 or 6, Red 3 or 40, and/or Blue 1 from the royal icing component used on the finished pops.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1581-2015.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Chocolate By Design, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1581-2015.
Chocolate By Design, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Chocolate By Design, Inc. Recall FAQ
Chocolate By Design, Inc. is the subject of a dairy safety report: Assorted Milk Chocolate Royal Icing Pops sold as Assorted Character Icing Pops, Christmas Icing Pops, and Triple Heart Icing Pops, 24 pop.... The notice was published on February 12, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 10 units are potentially affected.